Annual CAPEX
$296.00 K
+$203.00 K+218.28%
31 December 2023
Summary:
Zevra Therapeutics annual capital expenditures is currently $296.00 thousand, with the most recent change of +$203.00 thousand (+218.28%) on 31 December 2023. During the last 3 years, it has risen by +$263.00 thousand (+796.97%). ZVRA annual CAPEX is now at all-time high.ZVRA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Zevra Therapeutics quarterly capital expenditures is not available.ZVRA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Zevra Therapeutics TTM capital expenditures is not available.ZVRA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +218.3% | - | - |
| 3 y3 years | +797.0% | - | - |
| 5 y5 years | - | - | - |
ZVRA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +797.0% | ||||
| 5 y | 5 years | at high | +1038.5% | ||||
| alltime | all time | at high | +1038.5% |
Zevra Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $296.00 K(+218.3%) | $72.00 K(-58.1%) | $296.00 K(+14.7%) |
| Sept 2023 | - | $172.00 K(+647.8%) | $258.00 K(+126.3%) |
| June 2023 | - | $23.00 K(-20.7%) | $114.00 K(+7.5%) |
| Mar 2023 | - | $29.00 K(-14.7%) | $106.00 K(+14.0%) |
| Dec 2022 | $93.00 K(-8.8%) | $34.00 K(+21.4%) | $93.00 K(+22.4%) |
| Sept 2022 | - | $28.00 K(+86.7%) | $76.00 K(+46.2%) |
| June 2022 | - | $15.00 K(-6.3%) | $52.00 K(-55.9%) |
| Mar 2022 | - | $16.00 K(-5.9%) | $118.00 K(+15.7%) |
| Dec 2021 | $102.00 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $17.00 K(+325.0%) | $102.00 K(-8.1%) |
| Sept 2021 | - | $4000.00(-95.1%) | $111.00 K(+3.7%) |
| June 2021 | - | $81.00 K(+211.5%) | $107.00 K(+224.2%) |
| Dec 2020 | $33.00 K(+26.9%) | $26.00 K(>+9900.0%) | $33.00 K(+175.0%) |
| Sept 2020 | - | $0.00(-100.0%) | $12.00 K(-25.0%) |
| June 2020 | - | -$4000.00(-136.4%) | $16.00 K(-20.0%) |
| Mar 2020 | - | $11.00 K(+120.0%) | $20.00 K(+122.2%) |
| Dec 2019 | $26.00 K | $5000.00(+25.0%) | $9000.00(+125.0%) |
| Sept 2019 | - | $4000.00 | $4000.00 |
FAQ
- What is Zevra Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Zevra Therapeutics?
- What is Zevra Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Zevra Therapeutics?
- What is the all time high TTM CAPEX for Zevra Therapeutics?
What is Zevra Therapeutics annual capital expenditures?
The current annual CAPEX of ZVRA is $296.00 K
What is the all time high annual CAPEX for Zevra Therapeutics?
Zevra Therapeutics all-time high annual capital expenditures is $296.00 K
What is Zevra Therapeutics annual CAPEX year-on-year change?
Over the past year, ZVRA annual capital expenditures has changed by +$203.00 K (+218.28%)
What is the all time high quarterly CAPEX for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly capital expenditures is $172.00 K
What is the all time high TTM CAPEX for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM capital expenditures is $296.00 K